Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinib.
Sign Up to like & getrecommendations! Published in 2021 at "Future oncology"
DOI: 10.2217/fon-2020-1052
Abstract: Aims: Premarketing clinical trials are typically conducted under controlled conditions and in selected study populations, so real-world information on the utilization of new cancer drugs is limited. We aimed to explore the potential of German claims… read more here.
Keywords: utilization new; claims data; potential german; new cancer ... See more keywords